Skip to content

EXCELEVATE

Active
Private limited companyfounded 2019active for 7 yearsBoekstraat 38, 3500 Hasselt, BelgiumKBO/BCE: BE 0733.855.082
Summary

EXCELEVATE has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,273 and a net result of €12,539. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 11% of 21,076 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

History

EXCELEVATE was incorporated on 9 September 2019 as a private limited company.1 Total assets rose from €87,329 in 2020 to €116,892 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2020 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
10-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
24-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
17-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Highest result from 2020 to 2025net €57,469 ▲1,825%
Operating result €73,094, net result €57,469, both a record.
13-07
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Weakest financial yearnet €2,985 ▼57.1%
Net result drops to €2,985, the lowest in the series; recovery starts the following year.
15-06
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Liquidity more than doubledcurrent ratio 6.14
Current ratio from 2.78 to 6.14; short-term debt falls from €30,636 to €12,001.
14-06
NBB filing Annual accounts filed
financial year 2020 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts

We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.